Medical Science Liaison, Rare Diseases

The Medical Science Liaison (MSL) at Biogen provides field-based medical and scientific expertise across Emilia-Romagna and surrounding regions, building partnerships with healthcare professionals.Possiede le qualifiche e le competenze giuste per questo lavoro? Lo scopra qui sotto e invii la sua candidatura per essere preso/a in considerazione.This...

Role: Medical Science Liaison È questo il suo prossimo lavoro? Legga la descrizione completa qui sotto per scoprirlo e non esiti a candidarsi.Contract type: Permanent / Full Time Area to cover: Emilia-Romagna, Marche, Abruzzo e Molise Residenza/Domicilio: Emilia- Romagna Compensation package: Annual Gross Salary: €58.000 – €77.500. This salary range...

Overview In this Medical Science Liaison role, you will serve as the scientific bridge between Biogen and external healthcare professionals in the designated Italian regions. You will share up-to-date medical knowledge, gather insights, and support research activities to inform Medical Affairs planning. You will work cross-functionally to ensure compliant...

Emilia- RomagnaSi candidi rapidamente per massimizzare le sue possibilità di essere considerato/a per un colloquio. Legga la descrizione completa del lavoro qui sotto.Annual Gross Salary: €58.000 – €77.500. This salary range reflects the full-time base salary we expect to offer for this role at the time of posting. The base salary will be determined...

Biogen Italia seeks a Medical Science Liaison to cover Emilia-Romagna, Marche, Abruzzo and Molise from a dedicated base in Emilia‑Romagna.Si candidi (facendo clic sul pulsante apposito) dopo aver controllato tutte le informazioni di lavoro riportate di seguito.The MSL provides field-based medical and scientific expertise, builds partnerships with key...

Alfasigma is a privately held global healthcare company founded over 75 years ago in Italy, where it remains headquartered today in Bologna and Milan. The Group operates in over 100 markets spanning Europe, North and South America, Asia, and Africa.I candidati sono invitati a leggere attentamente tutti gli elementi di questo annuncio. La preghiamo di inviare...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri‑complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly...